M, consensus $430.97M. Analysts expect the company to report FY25 revenue of $543.99. Guidance taken from Investor Day. Shares of TransMedics (TMDX) are down 3.4% in afternoon trading. Pick the best ...
The New York-based company upped its adjusted per-share guidance for the current year to between 10 cents to 11 cents, up from its previous view for between 6 cents to 7 cents. It is now expecting ...